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A PREVIOUS study (Cherry and Glucksmann, 1965) of the histogenesis of
cancers induced by the injection of dimethylbenzanthracene (DMBA) into the
salivary glands of rats showed a sex difference in rate of induction of carcinomas.
The duration of risk of inducing carcinomas was found to be limited to a few
months, and that for sarcomas to extend over years; we observed that carcinomas
pass through various stages of development and before reaching full xenoplasia,
i.e. the ability to grow in various environments, they were likely to be strangled
by sarcomas developing in their neighbourhood. While carcinomas showed a
linear relation for cumulative percentage and time, sarcomas at first tended to
develop at a fast rate and later more slowly thus giving a biphasic graph.
The present report is concerned with the sex difference in the induction of
tumours of the salivary glands in rats and examines the process in intact and
castrate males and females. In addition each ofthe four groups has been treated
with testosterone, with stilboestrol or with testosterone plus stilboestrol. Because
of the influence of the thyroid on the submaxillary gland (Arvy, Debray and
Gabe, 1950; Arvy and Gabe, 1950a, b; Grad and Leblond, 1949; Hammett,
1923; Shafer and Muhler, 1956), we have also investigated the influence of
L-thyroxine and of methylthiouracil on tumour induction in intact and castrate
male and female rats. The sexual dimorphism of the salivary glands in rats and
mice (Grad and Leblond, 1949; Jacoby and Leeson, 1959; Junqueira, Fajer,
Rabinovitch and Frankenthal, 1949 ; Lacassagne, 1940a, b; Shafer and Muhler,
1953) has been established particularly with regard to the submandibular gland.
With radiation exposures a sex difference was observed for the induction of
adenomas in the sublingual gland (Glucksmann and Cherry, 1962). The present
research was undertaken to determine whether sex and thyroid hormones influence
carcinogenesis and if so at what stages and in which tissues and cells.
MATERIALS AND METHODS
For these experiments 521 black-hooded, laboratory bred rats aged 2 to 3
months were used. Each rat received under ether-anaesthesia an injection of
0.1 ml. of a saturated acetone solution of 9,10-dimethyl-1,2-benzanthracene
(DMBA) into the right and left salivary gland complex. In order to deposit
the carcinogen in all 3 salivary glands 0*05 ml. was injected in an anterior direction
into the submandibular plus sublingual gland and the other 0-05 ml. in a posterior
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direction into the parotid. Previous experiments with the injection of equal
amounts of acetone (Cherry and Glucksmann, 1965) had failed to induce any
tumours and were not repeated. Four to 6 weeks before the injection of DMBA,
122 males and 115 females were castrated surgically under ether anaesthesia.
A total of 112 intact and castrate male and female animals received no treat-
ment additional to the DMBA injection and were allowed to survive until clinical
symptoms of tumours appeared. Testosterone propionate (Ciba) in 30 mg.
pellets was inserted subcutaneously into 93 intact and castrate males and females.
Stilboestrol (B.P.) was added to the drinking water (01 mg./1000 ml.) of 83
intact and castrate males and females, making a daily dose of about 0.002 mg.
per rat. Another 79 intact and castrate males and females had testosterone
pellets inserted and were given stilboestrol in their drinking water. L-Thyroxine
sodium (Eltroxin, Glaxo) was added to the drinking water (1 mg./1000 ml.)
giving a daily dose of approximately 0-02 mg. for each of 77 intact and castrate
males and females. Methylthiouracil (B.D.H., 1 g./1000 ml.) was administered
in the drinking water to 77 intact and castrate males and females, i.e. a daily
dose of about 0.02 g. per rat.
At autopsy the salivary glands were fixed in Bouin's fluid and the tumours in
Zenker-acetic if they could be dissected from the gland complex. In addition
the pituitary, adrenals, thyroid and parathyroid, liver, spleen with pancreas,
kidneys and the gonads with cervix and uteri or seminal vesicles and prostate
were fixed and prepared for histological examination. After paraffin-embedding,
sections were cut at 8 It and stained with haematoxylin and eosin, the periodic
acid-Schiff technique with prior diastase digestion, Southgate's mucicarmine
stain, Van Gieson's method or with carmalum-aniline blue-orange G.
RESULTS
The first carcinoma verified histologically occurred 40 days and the first
sarcoma 41 days after the injection of the carcinogen. Some animals died or
had to be killed before this period and are not considered " at risk ". The main
cause for early death or killing was ulceration of the skin in the region of the
salivary glands and of the 521 rats, 69 were killed for this reason, i.e. 130%. In
the various treatment groups the incidence of ulceration varied from 6% in
animals given additionally methylthiouracil to 23% in those with testosterone
pellets. In both intact males and castrate females the incidence of ulceration
was 170% while in castrate males it was only 700 and in intact females 110%.
There is no correlation between the incidence ofulceration and that of carcinomas
or sarcomas nor between ulceration and the incidence of cancers according to
treatment groups, to sex or castration. In previous experiments injection was
made into one gland complex only either after surgical exposure or through the
skin. No definite variation in the incidence of ulceration with the mode of
inserting the carcinogen or with uni- or bilateral application could be discerned.
The latest tumours to develop allowed rats to survive for about 600 days
after injection of the DMBA. Others survived for up to 769 days after injection
without tumours. The animals were killed as soon as firm lumps were felt in
the treated region or when the rat appeared to suffer discomfort. Some animals
had intercurrent disease such as breast tumours, leukaemias, pituitary tumours
and, in the group treated with methylthiouracil, adenomas or carcinomas of theA. GLUCKSMANN AND C. P. CHERRY
thyroid. Castration caused adrenal hyperplasia, the appearance in the pituitary
of castration cells, which persisted in spite of stilboestrol administration, but
were eliminated by testosterone treatment of both males and females. Intact
and castrate females treated with testosterone ± stilboestrol showed ossification
in the clitoris. Epithelial cords and secretory ducts in the thymus occurred with
increasedfrequency after stilboestrol treatment andwere decreased bytestosterone
application (Cherry, Eisenstein and Glucksmann, 1967).
The effect ofseX, ca8tration, ofsex and thyroid hormones on theinduction ofcarcinomas
The results of the 24 experimental variations are illustrated in the histograms
ofFig. 1. The highest cancer incidence is seen in intact males and is significantly
greater than that in castrate males and in intact and castrate females. The
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FIw. 1.-Histograms showing the effect of sex, castration, L-thyroxine, methylthiouracil,
testosterone with and without stilboestrol and ofstilboestrol on the induction ofcarcinomas
in intact and castrate rats.
differences between these last three groups though striking do not reach the
95% confidence level. Their rate of development decreases in the same order
(Fig. 2) and suggests that as regards carcinomas intact males rank highest,
followed by castrate males, intact and lastly castrate females. All four groups
have a linear relation between increase in percentage and time and though many
animals survived for periods longer than 200 days no more carcinomas appeared
after that period.
As might be expected from these data, treatment with testosterone increases
and accelerates the induction of carcinoma in castrate males and in intact and
castrate females (Fig. 2). The final percentages are significantly increased in
intact and castrate females (Fig. 1), but only slightly in castrate males.
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Stilboestrol decreases and retards cancer induction significantly in intact males
and markedly in castrate males. It does not greatly influence the process in
intact and castrate females. As Fig. 1 shows, the general level ofcancer induction
in the four groups is lowered to almost the level of castrate females and thus
contrasts with the effect of testosterone.
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FIG. 2.-Graphs illustrating the influence of sex, castration, testosteitone with and without
stilboestrol and of stilboestrol on the induction of carcinomas. The standard errors are
indicated by vertical lines.
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The combined treatment with testosterone and 8stlboeBtrol closely approximates
treatment with testosterone only, causing the same high incidence of carcinomas
(Fig. 1), though not accelerating the process to the same extent (Fig. 2). These
experiments suggest that the incidence and rate of formation of carcinomas
increases with the " maleness " of animals.
The effects of treatment with L-thyroxine (Fig. 3) or with methylthiouracil
(Fig. 4) appear to be generally inhibitory on the incidence of carcinomas (Fig. 1),
methylthiouracil being more effective than L-thyroxine. The rate of carcino-
genesis however, is depressed more by L-thyroxine than by methylthiouracil
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FIG. 3.-Graph illustrating the influence of L-thyroxine on the induction of carcinomas in
intact and castrate male and female rats. The numerals " 608 " after the arrow indicate
that the tumour incidence remained at this level for the period of 608 days after injection.
The numerals in Fig. 3, 4, 7, 9, 10, 11 and 12 indicate a steady level of tumour incidence
up to the day indicated.
(Fig. 4). Both agents affect intact and castrate females more than intact and
castrate males, and indeed the effect on intact males is not significant except for
the slowing down oftumour development by L-thyroxine. In intact females and
castrate maleS L-thyroxine prolongs the period of risk of carcinogenesis very
significantly (Fig. 3) and in the castrate males changes the cumulative curve from
a straight line to a biphasic one. The greatest effect is seen in castrate females
with the suppression of carcinomas by methylthiouracil and their reduction by
L-thyroxine.
The differences in the reaction of animals with different sexual status to the
various agents used is illustrated by Fig. 5. Intact males produce carcinomas in
the 50 to 75% range with the exception of rats treated with stilboestrol. In
castrate males the range lies between 38 and 56%, again with the exception of
stilboestrol-treated animals. In intact females the cancer incidence varies
between 12% for methylthiouracil treatment and 72% for testosterone admini-
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FIG. 4.-Graph illustrating the influence of methylthiouracil onthe induction ofcarcinomas in
intact and castrate male and female rats.
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FIG. 5.--Histograms showing the effect of L-thyroxine, methylthiouracil, testosterone with
and without stilboestrol and of stilboestrol on the incidence of carcinomas in intact and
castrate male and female rats.
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stration. In castrate females the variations are even wider: 0% for methyl-
thiouracil, 6% for L-thyroxine, 63% for testosterone and 68% for testosterone
plus stilboestrol. It thus seems that "maleness " not only encourages the
production of carcinomas, but fixes the responsiveness to DMBA at a high level.
Castration increases the pronounced variability in the response of females to
hormonal treatments additional to DMBA administration as measured by the
induction of carcinomas.
The stage at which sex, sex hormones and thyroid hormones influence the
carcinogenic process appears to be linked with the formation of an epithelial cyst
and sinus from persisting glandular ducts which undergo squamous metaplasia.
The injected carcinogen causes necrosis ofparts of the glands, interferes with the
autolytic and phagocytic disposal of the necrotic tissue, elicits squamous meta-
plasia in persisting larger ducts which proceed to encyst the killed gland (Cherry
and Glucksmann, 1965). The enlarging cyst filled with debris and with exfoliated
keratinised -material tends to transform into a sinus which discharges its content
through the skin or into the buccal cavity. Carcinogenic material within the cyst
induces proliferation of the epithelium and its transformation into carcinomas.
Excessive necrosis may occur and lead to early ulceration which inhibits the
formation ofa sinusthough, depending onthe duration and extent ofthe ulcerative
process, anattemptat-epithelialisation ofthe debris may start from the epidermis,
andgive rise to the carcinomas appearing later (Fig. 3). Failure of the persisting
ducts to proliferate and to undergo squamous metaplasia is another reason why
sinuses do not develop. The incidence and extent ofsquamous metaplasia differs
greatly in the two sexes, being much less in females than in males. In females
this reaction of regenerating ducts is further inhibited by L-thyroxine, methyl-
thiouraciland stilboestrol, but markedly increased by testosterone. In males too
stilboestrol decreases the incidence and extent of squamous metaplasia. It is
noteworthy that squamous metaplasia and with it sinus formation are reduced
in all experiments in which the incidence of carcinomas is low. There is also
very good correlation within a givenexperiment between squamous metaplasia,
sinus and carcinoma formation which are found in rats with, and are absent in
those without tumours.
Sinuses also account for the limitation in time of cancer risks: the toxic
effects of the encysted carcinogen-impregnated debris together with the enlarge-
mentdueto accumulated exfoliated material causethinning ofthe sinus epithelium
and unless carcinoma formation has supervened, the sinus bursts and its contents
come into contact with the surrounding stroma where it may elicit the formation
ofsarcomas. With the disappearance ofthe sinus the risk of carcinoma develop-
mentdisappears. The carcinogen canproduce carcinomas only if in contact with
the cuticular surface of an epithelium, while at its basal surface it comes into
contact with mesenchymal elements and elicits sarcomas.
Theeffectofsex, castration, ofsex andthyroid hormones on the induction ofsarcomas
The final results of the 24 modifications of experimental conditions on the
formation of sarcomas are given in the histograms of Fig. 6 and show much less
variation than those for carcinoma induction by the same means (Fig. 1). If
the cumulative incidence of sarcomas is plotted against time (Fig. 7) differences
in rate ofdevelopment can be discerned though they are not as great as in the
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FIG. 6.-Histograms showing the effect of sex, castration, L-thyroxine, methylthiouracil,
testosterone with and without stilboestrol and of stilboestrol on the induction of sarcomas
in intact and castrate rats. (See Fig. 1 for key).
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carcinomas (Fig. 2). Nevertheless sarcoma induction is more rapid in intact
males than in intact females and is intermediate in the castrate animals. The
cumulative incidence in all 4 groups is biphasic with a steep initial and a more
gradual subsequent slope, which extends to about 500 days in the spayed females.
The late development of some sarcomas obscures differences between the various
experimental groups, which can be shown in the incidence of sarcomas present
at 200 days after the injection of the carcinogen (Fig. 8). The percentage of
sarcomas is significantly decreased in intact males by treatment with stilboestrol,
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at 200 days after injection in intact and castrate rats. (See Fig. 1 for key).
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FIG. 8.-Histograms showing the effect of sex, castration, L-thyroxine, methylthiouracil,
testosterone with and without stilboestrol, and of stilboestrol on the induction of sarcomas
at 200 days after injection in intact and castrate rats. (See Fig. 1 for key).
in castrate males by stilboestrol and also by L-thyroxine, in intact females greatly,
but not significantly, by L-thyroxine and in spayed females moderately by
L-thyroxine and by methylthiouracil. The incidence of sarcomas is increased
significantly by testosterone in intact females and by testosterone plus stilboestrol
in spayed females.
The rates of sarcoma induction in testosterone and stilboestrol treated rats is
shown in Fig. 9. Except for testosterone treated intact males the graphs are
again biphasic. The treated animals fall distinctly into 2 groups according to
the hormonal treatment as indicated by the arrow. Testosterone accelerates and
stilboestrol slows down, but extends in time the development ofsarcomas. Treat-
ment with testosterone plus stilboestrol (Fig. 10) closely approximates the effect
of testosterone alone. L-thyroxine retards the induction of sarcomas (Fig. 11)
as it does that of carcinomas (Fig. 3) and again more in females than in males,
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FIG. 9.-Graph illustrating the influence oftestosterone and ofstilboestrol on the induction of sarcomas in intact and castrate male and female rats. The arrow indicates the gap between testosterone and stilboestrol treated animals.
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FIG. 10.-Graph illustrating the influence of testosterone plus stilboestrol on the induction of
sarcomas in intact and castrate male and female rats.770
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FIG. 11.-Graph illustrating the influence ofL-thyroxine on the induction ofsarcomas in intact
and castrate male.and female rats.
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FIG. 12.-Graph illustrating the influence of methylthiouracil on the induction of sarcomas in
intact and castrate male and female rats.
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but the inhibition ofsarcomas in spayed females does not equal that ofcarcinomas.
In all four groups of animals methylthiouracil (Fig. 12) has only a slight effect
on the development of sarcomas and does not inhibit or even prevent sarcoma
formation as it does carcinomas in the intact and castrate females (Fig. 3).
The final percentage ofinduced sarcomas (Fig. 13) has the same range in intact
and castrate males and females, i.e. 68 to 84% for intact males with the exception
of52% for stilboestrol treatment, 67 to 95% for castrate males with the exception
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FIG. 13. Histograms showing the effect of L-thyroxine, methylthiouracil, testosterone with
and without stilboestrol and of stilboestrol on the incidence of sarcomas in intact and
castrate male and female rats.
of59% for L-thyroxine treatment, 67 to 92% for intact females with the exception
of 56% for L-thyroxine treatment and 69 to 100% for castrate females. From
these data it might appear that the sensitivity of the stroma to the carcinogen is
not affected by hormonal treatment. A similar analysis for sarcoma induction
by 200 days (Fig. 14) presents a different picture, however; as for carcinomas
(Fig. 4) the intact males show an effect only of stilboestrol and remarkably
constant levels for all other treatments. The variability in response of castrate
males is much greater with low levels for stilboestrol and L-thyroxine and with
high ones in the testosterone treated and the control groups. Intact females have
high incidences in the testosterone, stilboestrol and testosterone plus stilboestrol
groups and a low one in the L-thyroxine treated animals. In castrate females the
testosterone and testosterone plus stilboestrol treated rats form a high level
group and those treated with L-thyroxine and methylthiouracil a low-level one.
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Again the slow rate of development of sarcomas in the later periods obscures
differences in effectiveness of treatment.
The modification of sarcoma induction by the various changes in hormonal
conditions parallels that of carcinomas. Even for the final incidence the correla-
tion coefficient for carcinomas and sarcomas in the 24 experimental groups is
r = ± 0*499 + 0-21, but is considerably greater for carcinomas and the induction
of sarcomas by 200 days (Table I) when r = ± 0-666 + 0-21.
TABLE I.-The Influence of Various Hormonal Treatments on the Incidence of
Carcinonma and Sarcomas
Sarcoma Sarcoma
Treatment additional Number at present by absent day
to DMBA risk Carcinoma day 200 200 to 769
None . . . . 102 . 48 . 70 . 9
Testosterone . . 72 . 61 84 . 3
Testosterone+Stilboestrol . 72 . 58 . 78 . 6
Stilboestrol . . 69 . 28 51 17
L-Thyroxine . 65 . 31 48 22
Methylthiouracil . 72 . 26 . 58 158
The deposits of DMBA are initially more toxic to connective tissue than to
the epithelium and while inflammatory and fibroblastic reaction capable ofremov-
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proceeds with some success. In the later stages fibroblasts and inflammatory
cells which are adapted to the toxic effects of DMBA appear and form a capsule
and also the sarcomas. Since the animals were killed at the earliest sign of
tumour formation and since the early tumours are often carcinomas, it is natural
that sarcomas are not found in 100Oofthe rats at risk. Indeed a 100lOincidence
of sarcomas is seen only in castrate females given testosterone plus stilboestrol
and figures of 950 in castrate males without additional hormonal treatments and
in testosterone treated castrate males. The failure to produce sarcomas after
the end ofthe period ofrisk for carcinomas, i.e. from 200 days onward, varies with
the type oftreatment. Ofthe 452 animals at risk 54 or 120 did not have sarcomas
in the period from 200 to 769 days after injection. The percentage of negative
results was 100% for intact and 130% for castrate males, 110% for intact and 14o%
for castrate females. In the four control groups sarcomas were absent in 900,
but in only 3 o of testosterone and in 60% of testosterone plus stilboestrol treated
rats (Table I). In stilboestrol treated animals the failure rate rose to 170% and
was 18% for methylthiouracil and 220% for L-thyroxine treated rats. Within the
treatment groups the status ofthe gonads has a striking influence on the develop-
ment of sarcomas: in intact males given stilboestrol alone or in combination
with testosterone 200% of 40 rats did not have sarcomas, against only 60% of 85
rats not so treated. In castrated males treated with thyroxin or with methyl-
thiouracil the failure rate was 320% as compared with 400 in all other animals,
and in castrated females the respective figures are 230% and 80%.
In the absence of sarcomas the salivary glands are atrophic and usually
enclosed by a fibrotic and thickened capsule. The failure to produce sarcomas
may be due to a low sensitivity of the animals to the carcinogen which allows
them to form a stable scar and capsule. Alternatively early ulceration may have
been successful in discharging all of the carcinogen. We have no direct data
about the degree of ulceration in the individual animals which did not form
sarcomas later on. On the other hand, as mentioned above, we have information
about the number of animals which had to be killed early because of excessive
ulceration; if excessive ulceration is the main cause of inhibiting sarcomas, one
would expect some correlation between the percentage of animals showing early
ulceration and the failure rate for sarcoma production in the various experimental
groups. The correlation coefficient for these parameters is r = - 0.11 ± 0.21
which does not support the hypothesis. The variation in the failure to produce
sarcomas with treatment groups and the strong inverse correlation with the
incidence of carcinomas and of sarcomas up to 200 days (Table I) suggests that
the hormonal treatments have altered the sensitivity of the target tissues to the
carcinogen.
DISCUSSION
Quite apart from the differences in the incidence of cancers of accessory sex
organs such as the breast in men and women, there are appreciable variations in
the sex ratio for cancers of the buccal cavity, pharynx, larynx, oesophagus,
stomach, lung and bronchus which are twice to twenty times as frequent in males
as in females. Some of these differences can be attributed to environmental
factors such as occupational hazards, smoking and drinking which promote
carcinogenesis in males and which are reflected also in the variation inthe incidence
of some cancers in different countries and, within a country, with social status.A. GLUCKSMANN AND C. P. CHERRY
There are, however, possibly some factors inherent in the male and the female
which promote or inhibit the development of carcinomas at various sites. An
understanding of these factors might help us to use them in the prevention or in
the therapy of cancers at least as adjuvants to other techniques. The aim of the
experiments reported here is to elucidate in animals living in the same environment
what factors influence carcinogenesis in males and females. Because of the sex
dimorphism in the salivary glands (Lacassagne, 1940) we have chosen this system
in the hope of being able to discover sex-linked gradations of reaction to carcino-
gens.
The most obvious differences between male and female salivary glands are
concerned with the volume and secretory activity of the tubules ofthe submandi-
bular gland which in males greatly exceed those of females and which diminish
after castration or hormonal treatments (Arvy et al., 1950; Grad and Leblond,
1949; Jacoby and Leeson, 1959; Lacassagne, 1940a, b; Shafer and Muhler,
1956). The male submandibular gland of mice also produces more of the nerve
growth factor (Levi-Montalcini, 1965) and of the epidermal growth factor (Cohen,
1965) than the female, though the secretion can be stimulated in the female by
testosterone. Irradiation injures the acini and induces regeneration from the
secretory tubules of the submandibular and the intercalated ducts of the sub-
lingual glands which later result in the appearance of adenomas, and both these
processes are more marked in males than in females. With locally applied
carcinogens Steiner (1942) and Bauer and Byrne (1950) failed to find any sex
difference in carcinogenesis, though with feeding of carcinogens Heimail and
Meisel (1946) and Reuber (1960) did find an effect of sex. The present series of
experiments demonstrates a sex difference in the induction of carcinomas and to
a lesser extent also of sarcomas, but these differences are not linked with the
morphological dimorphism of the submandibular. In fact all three glands react
in the same manner and the variation with sex in tumour incidence concerns
sarcomas as well as carcinomas, a fact not obvious in our previously reported
experiments (Cherry and Glucksmann, 1965), in which, at least in the females onlv
the left side of the glandular complex was injected with the carcinogen and com-
parison between the two sexes was based on this procedure. In the present series
consistently fewer sarcomas are induced and more slowly in females than in males
and testosterone promotes and accelerates, while stilboestrol inhibits and retards
the formation of these tumours. There is also a significant correlation between
carcinoma and sarcoma induction in these experiments, particularly if the first
200 days after injection are considered. In the previously recorded experiments
the rate of sarcoma formation in females was slower than that in males (cf. Fig.
21, Cherry and Glucksmann, 1965) but in the absence of confirmatory evidence
the difference was not considered significant at that time. Subsequent results
have established this difference as consistent and real. The sex difference in the
induction of carcinomas is greater and always consistent.
For carcinomas the influence of sex and sex hormones is decisive at the stage
of sinus formation and encystation of the necrotic glandular mass that contains
and retains the DMBA as crystals. In the larger ducts of all three major glands
proliferation of the epithelium with squamous metaplasia is one of the conditions
for encystation, and is greater in males than females and is promoted by testo-
sterone and inhibited by stilboestrol. It is tempting to link the greater capacitv
for epithelial regeneration in males with the larger production of the epidermal
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growth factor in the submandibular gland and thus ultimately with the higher
incidence of carcinomas. There is no evidence that the same factors are respon-
sible for the more frequent and rapid proliferation of adapted fibroblasts leading
to the appearance of sarcomas. These sex and hormonal effects are modifying
only and the capacity for these responses is present in males, females and castrates.
Indeed as Fig. 2 suggests, stilboestrol accelerates slightly the induction of carcino-
mas in castrate females, though the difference is not statistically significant.
A stimulating effect on the development of cervico-vaginal sarcomas by testo-
sterone and absence of such promotion by oestrogens is seen after application
of DMBA to the female genital tract (Cherry and Glucksmann, 1960). Castration
retards and very greatly reduces the incidence of such tumours and neither stil-
boestrol nor oestradiol, which stimulate the growth of the vaginal, cervical and
uterine stroma, accelerate and increase the development of sarcomas. Testo-
sterone, on the other hand, which fails to stimulate the growth of the normal
stroma of the female genital tract in castrate animals, promotes and increases
the production of sarcomas in the castrate rat, though it retards it in the intact
animal. Furthermore, while oestradiol and stilboestrol induce proliferation and
squamous metaplasia in the cervico-vaginal epithelium, they inhibit both these
processes in the ducts of salivary glands after DMBA-injection. Thus it seems
that the promoting action of testosterone on carcinogenesis and the lack ofgrowth
stimulation by stilboestrol in a DMBA-treated tissue may differ from their normal
role in the reproductive context. It should be remembered, however, that though
the doses of the hormones given are not greatly beyond the physiological level,
the long-term continuous application may well produce unphysiological conditions
and these may be reinforced by castration. In any case these experiments on
animals kept under the same environmental conditions establish clearly that sex
and sex hormones modify the cancer incidence and make it likely that inherent
differences in combination with environmental factors may be responsible for the
marked sex differences in human carcinomas.
That castration may add to the unphysiological conditions for hormonal actions
is illustrated clearly by the experiments with L-thyroxine and methylthiouracil.
Thyroidectomy affects the growth of the submaxillary gland in females more
than in males (Hammett, 1923). Methylthiouracil has little effect on the rate
of development of carcinomas in males, but reduces it in intact females and
suppresses it in the castrate females. L-Thyroxine has little influence on the
induction of carcinomas in intact males, slows it down in castrate males and
eveni more so in intact females and almost suppresses it in castrate females. The
effects of L-thyroxine and methylthiouracil on the incidence of sarcomas differ
from that on carcinomas in that methylthiouracil has no appreciable influence
oni sarcomas and L-thyroxine slows down the process almost equally in all four
groups. In the female genital tract treated with DMBA (unpublished results)
L-thyroxine as well as methylthiouracil accelerate and increase the production
of cervico-vaginal sarcomas in castrates, but inhibit and retard the induction of
vulval carcinomas. In intact rats the production of sarcomas is not greatly
affected by the application of either L-thyroxine or methylthiouracil. It is
surprising that as regards carcinogenesis, L-thyroxine and methylthiouracil
should have a similar action when their general effects on metabolism, on the
growth and secretion of the submaxillary gland (Arvy and Gabe, 1950a; Shafer
and Muhler, 1956), on the thyroid and on the pituitary are diametrically opposed.776 A. GLUCKSMANN AND C. P. CHERRY
As with the sex hormones, the action of thyroid hormones on carcinogenesis
appears to be different from that in their normal context. Thus the synergistic
action of thyroxine and testosterone (Grad and Leblond, 1949) and the antago-
nistic action of thyroxine and oestrogens (Arvy and Gabe, 1950b) on the increase
in size and secretory activity of the submaxillary gland are not simply paralleled
by the effect on the development of tumours. Here again the long continued
administration ofthe substances may be responsible for unphysiological conditions
in the animal and as the differences in the efficacy of the agents in intact and
castrate males and feinales show, castration adds to the abnormal status and
modifies the effects. It is probable that the difference in action of the sex and
thyroid hormones on tissues undergoing carcinogenesis is due to some general
metabolic rather than to a specific endocrine process.
SUMMARY
The right and left salivary gland complex of rats was injected witlh DAIBA
and the effect ofsex, castration and ofthe treatment with testosterone. stilboestrol,
testosterone plus stilboestrol, L-thyroxine and methylthiouracil on the induction
of carcinomas and sarcomas in male and female animals was studied.
The first carcinomas and sarcomas appeared after 40 days, the last carcinomas
before 200 days and the last sarcomas at about 500 days. The cumulative
percentage of carcinomas rose linearly with time, but that of sarcomas was
biphasic with an initial steep and a subsequent gradual slope.
More carcinomas were elicited more rapidly in males than in females and
castrated rats. The same applied to the induction of sarcomas particularly up
to 200 days, but in later stages the sex difference in incidence was obscured by
the tardy development of tumours.
Testosterone increased and accelerated the induction of carcinomas and
sarcomas in females and castrates while stilboestrol decreased and retarded
tumour development in all but intact female rats. Testosterone and stilboestrol
given simultaneously had an effect similar to testosterone alone.
L-Thyroxine slowed the development of carcinomas and sarcomas in intact
and castrate males and females and also lowered significantly the percentage of
carcinomas induced in intact and castrate females.
Methylthiouracil decreased the incidence of carcinomas in intact and even
more in castrate females, but had no significant effect on the rate of carcinogenesis
in males and on the development of sarcomas in both groups of females.
The authors are grateful to Professor Dame Honor B. Fell, F.R.S. for reading
the manuscript.
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